Bibliographie (2546)
![[Press release – not published yet] AstraZeneca vaccine 79% effective for preventing symptomatic COVID-19](/media/k2/items/cache/6cc1906906242cb93fd96a345b4d3e52_L.jpg)
[Press release – not published yet] AstraZeneca vaccine 79% effective for preventing symptomatic COVID-19
mardi, 23 mars 2021 05:30 Écrit par Zouhair SouissiAZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis – AstraZeneca Commentaries: AstraZeneca vaccine is 79% effective against symptomatic Covid-19, company says – CNN AND AstraZeneca’s Covid-19 vaccine shows better-than-expected efficacy in U.S. trial – STAT AND Expert reaction to press release from AstraZeneca announcing interim data on safety […]
The post [Press release – not published yet] AstraZeneca vaccine 79% effective for preventing symptomatic COVID-19 appeared first on Links Medicus.
Modeling Study: Vaccination alone is unlikely to contain COVID-19 infections in UK
lundi, 22 mars 2021 07:19 Écrit par Zouhair SouissiVaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study – The Lancet Infectious Diseases Commentaries: Risking further COVID-19 waves despite vaccination – The Lancet Infectious Diseases AND Vaccination alone is unlikely to contain COVID-19 infections in UK – The Lancet Commentary on Twitter Vaccination alone is unlikely to contain #COVID19 infections in UK, […]
The post Modeling Study: Vaccination alone is unlikely to contain COVID-19 infections in UK appeared first on Links Medicus.
Bioethics | “Europe’s Vaccine Ethics Call: Do No Harm and Let More Die?”
lundi, 22 mars 2021 07:19 Écrit par Zouhair SouissiEurope’s Vaccine Ethics Call: Do No Harm and Let More Die? – The New York Times (free registration may be required) Related opinion: Covid-19 vaccine adverse events: balancing monitoring with confidence in vaccines – The BMJ Opinion See also: European Medicines Agency finds AstraZeneca vaccine is safe and benefits outweigh the risks (Statement and commentaries) […]
The post Bioethics | “Europe’s Vaccine Ethics Call: Do No Harm and Let More Die?” appeared first on Links Medicus.
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review
lundi, 22 mars 2021 07:19 Écrit par Zouhair SouissiRecent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review – Journal of the American College of Cardiologyv Commentary on Twitter @JACCJournals: We share a systematic summary of #anticcogulation,#antiplatelet, and #fibrinolysis #RCTs in #COVID19. Amazing work by @AzitaTalasaz and a stellar multidisciplinary team! Figs illustrate areas where we’ll have evidence, & the gaps. Link: https://t.co/t4ksxwjAze […]
The post Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review appeared first on Links Medicus.
![[Preprint] Oxford/AstraZeneca and Pfizer/BioNTech vaccines probably can still neutralize P.1 strain of SARS-CoV-2, but at lower levels](/media/k2/items/cache/65829020f6ea67f48aa759d3dd32c68a_M.jpg)
[Preprint] Oxford/AstraZeneca and Pfizer/BioNTech vaccines probably can still neutralize P.1 strain of SARS-CoV-2, but at lower levels
lundi, 22 mars 2021 07:19 Écrit par Zouhair SouissiAntibody evasion by the Brazilian P.1 strain of SARS-CoV-2 – bioRxiv Commentary: Existing COVID vaccines may protect against Brazilian variant – Oxford study – Reuters
The post [Preprint] Oxford/AstraZeneca and Pfizer/BioNTech vaccines probably can still neutralize P.1 strain of SARS-CoV-2, but at lower levels appeared first on Links Medicus.
B.1.351 strain of SARS-CoV-2 neutralization titer reduced 8- to 9-fold for Pfizer and AstraZeneca vaccinees. Convalescent plasma and therapeutic antibodies were less effective against this variant as well.
lundi, 22 mars 2021 07:19 Écrit par Zouhair SouissiEvidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera – Cell
The post B.1.351 strain of SARS-CoV-2 neutralization titer reduced 8- to 9-fold for Pfizer and AstraZeneca vaccinees. Convalescent plasma and therapeutic antibodies were less effective against this variant as well. appeared first on Links Medicus.
Infection and mRNA vaccine-induced immunity may be retained against SARS-CoV-2 variant B.1.1.7
lundi, 22 mars 2021 07:19 Écrit par Zouhair SouissiNeutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination – JAMA
The post Infection and mRNA vaccine-induced immunity may be retained against SARS-CoV-2 variant B.1.1.7 appeared first on Links Medicus.
SARS-CoV-2 variants B.1.351 and P.1 can escape from therapeutic antibodies and evade antibodies induced by infection or mRNA vaccination
lundi, 22 mars 2021 07:19 Écrit par Zouhair SouissiSARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies – Cell
The post SARS-CoV-2 variants B.1.351 and P.1 can escape from therapeutic antibodies and evade antibodies induced by infection or mRNA vaccination appeared first on Links Medicus.
Expert consensus statements for the management of COVID-19-related acute respiratory failure
lundi, 22 mars 2021 07:19 Écrit par Zouhair SouissiExpert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method – Critical Care Commentary on Twitter ?Expert consensus statements for the management of ?? COVID-19-related acute respiratory failure using a Delphi method.?????https://t.co/ujt8669VAb pic.twitter.com/AlT0ZkdKSc — RECAT??⚕️???⚕️ (@LeslieMegom) March 17, 2021
The post Expert consensus statements for the management of COVID-19-related acute respiratory failure appeared first on Links Medicus.
Perspective | Five reasons why COVID herd immunity is probably impossible
vendredi, 19 mars 2021 10:01 Écrit par Zouhair SouissiFive reasons why COVID herd immunity is probably impossible – Nature
The post Perspective | Five reasons why COVID herd immunity is probably impossible appeared first on Links Medicus.
